Flu Vaccine Market
Flu Vaccine Market Study by Trivalent Flu Vaccines and Quadrivalent Flu Vaccines in Intramuscular Injections, Nasal Sprays, and Intradermal Shots from 2024 to 2034
Analysis of Flu Vaccine Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
FREE CustomizationFlu Vaccine Market Outlook (2024 to 2034)
The flu vaccine market size is experiencing a steady and continuous growth rate, with an estimated valuation of US$ 5,831.7 million in 2024. The market is anticipated to grow at a CAGR of 6.7% from 2024 to 2034, reaching a value of more than US$ 11,181.3 million by 2034.
The government's numerous campaigns to encourage vaccination against the flu are stimulating growth in the market. As more individuals take proactive steps to protect themselves and realize how important it is to be vaccinated against influenza, the industry is predicted to see a spike in demand.
Key Market Growth Drivers
- Vaccinations are recommended to prevent influenza, with various types available, including live attenuated, recombinant, adjuvant, and inactivated vaccines. The rapid global spread of influenza outbreaks necessitates an effective vaccine.
- Sales of vaccines are anticipated to rise throughout the projection period as a result of increasing seasonal flu cases and more robust recommendations for immunization against the illness.
- Furthermore, one of the reasons driving the market's growth is the increase in government support and surveillance surrounding vaccination at both national and international levels. These efforts are aimed at monitoring vaccine distribution, supply, and administration.
Throughout the projection period, the flu vaccine market is anticipated to develop rapidly, led mainly by a strong product pipeline. The industry is expected to grow steadily over the next ten years as more and more novel and potent vaccines are being created and made available. This is expected to create significant opportunities for current companies and startups to benefit from the rising demand for flu vaccinations.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 5,831.7 million |
| Forecasted Market Value (2034F) | US$ 11,181.3 million |
| Global Market Growth Rate (2024 to 2034) | 6.7% CAGR |
| Quadrivalent Flu Vaccine Segment Growth Rate (2024 to 2034) | 6.8% |
| Intramuscular Injection Segment Growth Rate (2024 to 2034) | 6.7% |
| North America Market Share (2024) | 63.3% |
| East Asia Market Share (2024) | 11.7% |
| Key Companies Profiled | Sanofi Pasteur Inc.; AstraZeneca; Csl Ltd.; Abbott; GlaxoSmithKline Plc.; Serum Institute Of India Pvt.Ltd; Seqirus; AstraZeneca; FluGen, Inc.; Moderna, Inc.; Biocryst Pharmaceuticals, Inc.; CPL Biologicals Pvt. Ltd.; CureVac AG; OSIVAX; Solaris Vaccines |
Which Factors are Driving the Global Surge in the Flu Vaccines Industry?
“Rise in Clinical Studies for New Product Development Fuels Market Growth”
The flu vaccine market is predicted to expand considerably throughout the forecast period. Numerous causes, including the rise in clinical trials that market participants are conducting for the development of new products, contributed to this expansion. Further, the demand is rising due to the expansion of regular immunization programs, including influenza vaccinations, in developed and developing nations.
The market is expanding as a result of government campaigns encouraging the use of influenza vaccinations and the low risk of adverse effects from immunization. Moreover, corporations' financing and expenditures in research and development initiatives support the expansion of the worldwide market. The worldwide influenza vaccine market is anticipated to grow as a result of these combined reasons, making it a viable market for investors and participants in the sector.
“Broadening Inactivated Vaccine Adoption Rate Boosting Market”
The inactivated influenza vaccine is vital for stopping and managing the influenza virus's transmission. The most widely used type of flu vaccination, these shots are considered safe and effective since they are derived from dead forms of the virus. A significant benefit of inactivated influenza vaccinations is their high degree of safety.
A live flu infection cannot be caused by the viral strains used in these vaccinations since they are lifeless. Pregnant ladies, children, and people with depleted immune systems are among the masses who are at risk of developing severe complications from the flu and are good candidates for inactivated immunizations.
Growing awareness of the danger of influenza and a spike in the demand for flu shots are driving the inactivated sector.
What are the Challenges Present in the Flu Vaccine Market?
“Prolonged Duration for Flu Vaccine Preparation to Restrain its Sales”
The development of a new vaccine is complicated and the drawn-out procedure typically takes ten years. The complexity of clinical development, vaccination research, and regulatory compliance are restraining the growth of the market. There are regional variations in the regulatory frameworks about clinical trials, which causes delays in the development of novel vaccinations.
Moreover, data from several nations or areas are frequently needed for regulatory approval. However, the prolonged deadlines and extra labeling requirements in many countries make global clinical research difficult. Therefore, the market expansion is anticipated to be hampered by the stringent regulatory requirements and longer timeframes for performing clinical studies.
Country-wise Insights
The influenza vaccine market in North America is predicted to grow at an impressive 6.8% CAGR through 2034. The main impetus for the study is the increasing need in significant international markets, such as the United States and Canada, for drugs that reduce cold and flu symptoms. In 2024, flu treatments are expected to account for 95.0% of the United States’ industry.
Currently, the East Asia upper respiratory infection cough medication market is expected to rise at a 7.2% CAGR through 2034. In 2024, Japan is anticipated to dominate the East Asian flu vaccine market with a 53.1% market share.
Why is the United States Dominating the Global Flu Vaccine Market?
“Advanced Government Healthcare Initiatives in the United States”
| Attribute | Details |
|---|---|
| Market Value in 2024 | US$ 3,508 million |
| CAGR (2024 to 2034) | 6.8% |
The demand for influenza-related treatments is expected to increase considerably in the United States, with a projected market value of US$ 3,508 million in 2024. Moreover, the estimated CAGR during the forecast period is 6.8%, which is quite promising. This growth is expected to result in a market value of US$ 6,787 million by 2034.
The market is experiencing a significant boost due to various government programs and initiatives. One major contributor to this trend is the joint research and development efforts of several key organizations in the United States, including the Department of Health and Human Services, BARDA, NIH, CDC, and FDA. To reduce the effects of influenza on public health, several organizations are collaborating to create more potent and effective vaccinations.
The advisory council also promotes immunization as a vital tactic for stopping the spread of the flu and lessening its consequences on people and communities. These organizations support a healthier and more resilient population now and in the future by funding research and encouraging universal vaccination.
Why is Japan Considered a Thriving Market for Flu Vaccines?
“Rising Prevalence of Influenza Medicine Drives Japanese Healthcare Industry”
| Attribute | Details |
|---|---|
| Market Value in 2024 | US$ 361 million |
| CAGR (2024 to 2034) | 7.2% |
Japan's market for treating influenza is expected to grow and reach a projected value of US$ 361 million in 2024. Japan is also expected to account for a 53.1% share of the East Asian flu vaccine market in 2024. This market has been steadily growing in recent years. It is expected to increase at a CAGR of 7.2% from 2024 to 2034.
The healthcare industry in Japan is experiencing significant growth due to aspects such as a geriatric population, advanced healthcare infrastructure, and new market entrants. Japan's large population necessitates tailored healthcare services, making it a critical advancement region.
The country's high disease transmission rate underscores the need for advanced solutions. As a result, healthcare providers and stakeholders are investing heavily in research and development to improve patient outcomes and healthcare quality. The country’s large population and the need for cutting-edge solutions to prevent and treat diseases effectively drive this growth.
Category-wise Insights
In 2024, the quadrivalent flu vaccine segment dominates the market, constituting 84.0% of the global flu vaccine market share. Meanwhile, the trivalent flu vaccine category is predicted to hold a stable and diversified position, accounting for 16.0% of the market, thereby contributing to the overall growth and sustainability of the industry.
According to industry experts, in 2024, intramuscular injection is predicted to become the dominant mode of administering the influenza vaccine, accounting for 93.6% of the market share, depending upon the specific indication. Moreover, the nasal spray segment is projected to gain a noteworthy market share of 5.4% in 2024, contributing significantly to the global flu vaccination market.
What is Propelling Higher Demand for Quadrivalent Flu Vaccines?
“Cost-effectiveness and Easy Availability of Quadrivalent Flu Vaccines”
| Attribute | Details |
|---|---|
| Market Share in 2024 | 84.0% |
In 2024, the quadrivalent flu segment dominated the market with a share of 84.0%, indicating the widespread acceptance and preference of this vaccine among the masses. This segment is projected to grow rapidly over the forecast period, owing to its high efficacy against viral infections. The demand for quadrivalent flu vaccine solutions is also expected to increase, with an estimated consumption value of US$ 4,899.2 million in 2024.
The popularity of this vaccine is due to its cost-effectiveness, easy availability in clinics & hospitals, and a higher preference for quadrivalent vaccines by medical professionals. The quadrivalent flu vaccine is developed to defend against four different influenza virus strains, which makes it more effective than the traditional trivalent flu vaccine that protects against three strains. The quadrivalent flu vaccination is quickly emerging as the public's vaccine of choice for preventing influenza.
Competitive Landscape
Market players in the healthcare industry are actively investing in research and development to enhance their product offerings for the treatment of influenza. These companies are also strategically expanding their global presence by introducing new products, entering contractual agreements, pursuing mergers and acquisitions, increasing investments, and fostering collaboration.
The flu vaccine sector is facing intense competition, and to thrive in this environment, industry players are focused on providing affordable products. These players prioritize FDA clearance and forging regional distribution partnerships to increase their market share and earnings. Additionally, manufacturers employ local production to reduce operating costs, enhance customer experience, and expand their market reach.
Recent Developments
- In December 2023, scientists from the University of Pittsburgh discovered that individuals who receive a trivalent flu vaccine produce an antibody that overcomes a viral hurdle, effectively preventing both dominant flu subtypes.
- In October 2023, Pfizer Inc. and BioNTech SE reported encouraging findings from a phase 1 trial of an mRNA-based COVID-19 and influenza combination vaccine.
- In May 2023, Novavax, Inc. reported positive phase 2 trial results for three influenza vaccine candidates, demonstrating robust immune responses, safety profiles, and comparable reactogenicity to authorized comparators.
Segmentation of Flu Vaccine Market
-
By Product:
- Trivalent Flu Vaccine
- Quadrivalent Flu Vaccine
-
By Dosage Form:
- Intramuscular Injection
- Nasal Spray
- Intradermal Shot
-
By Distribution Channel:
- Institutional Sales
- Retail Sales
-
By Region:
- North America
- Europe
- East Asia
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
- 5.1. Trivalent Flu Vaccine
- 5.2. Quadrivalent Flu Vaccine
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
- 6.1. Intramuscular Injection
- 6.2. Nasal Spray
- 6.3. Intradermal Shot
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
- 7.1. Institutional Sales
- 7.1.1. Hospitals
- 7.1.2. Community Clinics
- 7.1.3. Public Health Agencies
- 7.1.4. Workplace Purchasing
- 7.2. Retail Sales
- 7.2.1. Retail Pharmacies
- 7.2.2. Mail Order Pharmacies
- 7.1. Institutional Sales
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Western Europe
- 8.4. Eastern Europe
- 8.5. South Asia and Pacific
- 8.6. East Asia
- 8.7. Middle East and Africa
- 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 16. Key Countries Market Analysis
- 17. Market Structure Analysis
- 18. Competition Analysis
- 18.1. Sanofi Pasteur Inc.
- 18.2. AstraZeneca
- 18.3. Sinovac
- 18.4. Abbott
- 18.5. GlaxoSmithKline Plc.
- 18.6. Serum Institute Of India Pvt.Ltd
- 18.7. Merck & Co., Inc
- 18.8. BioNTech
- 18.9. Pfizer
- 18.10. Moderna, Inc.
- 19. Assumptions & Acronyms Used
- 20. Research Methodology
List Of Table
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2019 to 2034
Table 2: Global Market Volume (Units) Forecast by Region, 2019 to 2034
Table 3: Global Market Value (US$ Mn) Forecast by Product, 2019 to 2034
Table 4: Global Market Volume (Units) Forecast by Product, 2019 to 2034
Table 5: Global Market Value (US$ Mn) Forecast by Dosage Form, 2019 to 2034
Table 6: Global Market Volume (Units) Forecast by Dosage Form, 2019 to 2034
Table 7: Global Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 8: Global Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 9: North America Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 10: North America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 11: North America Market Value (US$ Mn) Forecast by Product, 2019 to 2034
Table 12: North America Market Volume (Units) Forecast by Product, 2019 to 2034
Table 13: North America Market Value (US$ Mn) Forecast by Dosage Form, 2019 to 2034
Table 14: North America Market Volume (Units) Forecast by Dosage Form, 2019 to 2034
Table 15: North America Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 16: North America Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 17: Latin America Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 18: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 19: Latin America Market Value (US$ Mn) Forecast by Product, 2019 to 2034
Table 20: Latin America Market Volume (Units) Forecast by Product, 2019 to 2034
Table 21: Latin America Market Value (US$ Mn) Forecast by Dosage Form, 2019 to 2034
Table 22: Latin America Market Volume (Units) Forecast by Dosage Form, 2019 to 2034
Table 23: Latin America Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 24: Latin America Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 25: Western Europe Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 26: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 27: Western Europe Market Value (US$ Mn) Forecast by Product, 2019 to 2034
Table 28: Western Europe Market Volume (Units) Forecast by Product, 2019 to 2034
Table 29: Western Europe Market Value (US$ Mn) Forecast by Dosage Form, 2019 to 2034
Table 30: Western Europe Market Volume (Units) Forecast by Dosage Form, 2019 to 2034
Table 31: Western Europe Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 32: Western Europe Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 33: Eastern Europe Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 34: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 35: Eastern Europe Market Value (US$ Mn) Forecast by Product, 2019 to 2034
Table 36: Eastern Europe Market Volume (Units) Forecast by Product, 2019 to 2034
Table 37: Eastern Europe Market Value (US$ Mn) Forecast by Dosage Form, 2019 to 2034
Table 38: Eastern Europe Market Volume (Units) Forecast by Dosage Form, 2019 to 2034
Table 39: Eastern Europe Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 40: Eastern Europe Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 41: South Asia and Pacific Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 42: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034
Table 43: South Asia and Pacific Market Value (US$ Mn) Forecast by Product, 2019 to 2034
Table 44: South Asia and Pacific Market Volume (Units) Forecast by Product, 2019 to 2034
Table 45: South Asia and Pacific Market Value (US$ Mn) Forecast by Dosage Form, 2019 to 2034
Table 46: South Asia and Pacific Market Volume (Units) Forecast by Dosage Form, 2019 to 2034
Table 47: South Asia and Pacific Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 48: South Asia and Pacific Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 49: East Asia Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 50: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034
Table 51: East Asia Market Value (US$ Mn) Forecast by Product, 2019 to 2034
Table 52: East Asia Market Volume (Units) Forecast by Product, 2019 to 2034
Table 53: East Asia Market Value (US$ Mn) Forecast by Dosage Form, 2019 to 2034
Table 54: East Asia Market Volume (Units) Forecast by Dosage Form, 2019 to 2034
Table 55: East Asia Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 56: East Asia Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 57: Middle East and Africa Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 58: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034
Table 59: Middle East and Africa Market Value (US$ Mn) Forecast by Product, 2019 to 2034
Table 60: Middle East and Africa Market Volume (Units) Forecast by Product, 2019 to 2034
Table 61: Middle East and Africa Market Value (US$ Mn) Forecast by Dosage Form, 2019 to 2034
Table 62: Middle East and Africa Market Volume (Units) Forecast by Dosage Form, 2019 to 2034
Table 63: Middle East and Africa Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 64: Middle East and Africa Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
List Of Figures
Figure 1: Global Market Value (US$ Mn) by Product, 2024 to 2034
Figure 2: Global Market Value (US$ Mn) by Dosage Form, 2024 to 2034
Figure 3: Global Market Value (US$ Mn) by Distribution Channel, 2024 to 2034
Figure 4: Global Market Value (US$ Mn) by Region, 2024 to 2034
Figure 5: Global Market Value (US$ Mn) Analysis by Region, 2019 to 2034
Figure 6: Global Market Volume (Units) Analysis by Region, 2019 to 2034
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 9: Global Market Value (US$ Mn) Analysis by Product, 2019 to 2034
Figure 10: Global Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 13: Global Market Value (US$ Mn) Analysis by Dosage Form, 2019 to 2034
Figure 14: Global Market Volume (Units) Analysis by Dosage Form, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by Dosage Form, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by Dosage Form, 2024 to 2034
Figure 17: Global Market Value (US$ Mn) Analysis by Distribution Channel, 2019 to 2034
Figure 18: Global Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 19: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 20: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 21: Global Market Attractiveness by Product, 2024 to 2034
Figure 22: Global Market Attractiveness by Dosage Form, 2024 to 2034
Figure 23: Global Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 24: Global Market Attractiveness by Region, 2024 to 2034
Figure 25: North America Market Value (US$ Mn) by Product, 2024 to 2034
Figure 26: North America Market Value (US$ Mn) by Dosage Form, 2024 to 2034
Figure 27: North America Market Value (US$ Mn) by Distribution Channel, 2024 to 2034
Figure 28: North America Market Value (US$ Mn) by Country, 2024 to 2034
Figure 29: North America Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 30: North America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 33: North America Market Value (US$ Mn) Analysis by Product, 2019 to 2034
Figure 34: North America Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 37: North America Market Value (US$ Mn) Analysis by Dosage Form, 2019 to 2034
Figure 38: North America Market Volume (Units) Analysis by Dosage Form, 2019 to 2034
Figure 39: North America Market Value Share (%) and BPS Analysis by Dosage Form, 2024 to 2034
Figure 40: North America Market Y-o-Y Growth (%) Projections by Dosage Form, 2024 to 2034
Figure 41: North America Market Value (US$ Mn) Analysis by Distribution Channel, 2019 to 2034
Figure 42: North America Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 43: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 44: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 45: North America Market Attractiveness by Product, 2024 to 2034
Figure 46: North America Market Attractiveness by Dosage Form, 2024 to 2034
Figure 47: North America Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 48: North America Market Attractiveness by Country, 2024 to 2034
Figure 49: Latin America Market Value (US$ Mn) by Product, 2024 to 2034
Figure 50: Latin America Market Value (US$ Mn) by Dosage Form, 2024 to 2034
Figure 51: Latin America Market Value (US$ Mn) by Distribution Channel, 2024 to 2034
Figure 52: Latin America Market Value (US$ Mn) by Country, 2024 to 2034
Figure 53: Latin America Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 54: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 57: Latin America Market Value (US$ Mn) Analysis by Product, 2019 to 2034
Figure 58: Latin America Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 59: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 61: Latin America Market Value (US$ Mn) Analysis by Dosage Form, 2019 to 2034
Figure 62: Latin America Market Volume (Units) Analysis by Dosage Form, 2019 to 2034
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Dosage Form, 2024 to 2034
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Dosage Form, 2024 to 2034
Figure 65: Latin America Market Value (US$ Mn) Analysis by Distribution Channel, 2019 to 2034
Figure 66: Latin America Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 67: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 68: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 69: Latin America Market Attractiveness by Product, 2024 to 2034
Figure 70: Latin America Market Attractiveness by Dosage Form, 2024 to 2034
Figure 71: Latin America Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 72: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 73: Western Europe Market Value (US$ Mn) by Product, 2024 to 2034
Figure 74: Western Europe Market Value (US$ Mn) by Dosage Form, 2024 to 2034
Figure 75: Western Europe Market Value (US$ Mn) by Distribution Channel, 2024 to 2034
Figure 76: Western Europe Market Value (US$ Mn) by Country, 2024 to 2034
Figure 77: Western Europe Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 78: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 79: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 80: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 81: Western Europe Market Value (US$ Mn) Analysis by Product, 2019 to 2034
Figure 82: Western Europe Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 83: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 84: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 85: Western Europe Market Value (US$ Mn) Analysis by Dosage Form, 2019 to 2034
Figure 86: Western Europe Market Volume (Units) Analysis by Dosage Form, 2019 to 2034
Figure 87: Western Europe Market Value Share (%) and BPS Analysis by Dosage Form, 2024 to 2034
Figure 88: Western Europe Market Y-o-Y Growth (%) Projections by Dosage Form, 2024 to 2034
Figure 89: Western Europe Market Value (US$ Mn) Analysis by Distribution Channel, 2019 to 2034
Figure 90: Western Europe Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 91: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 93: Western Europe Market Attractiveness by Product, 2024 to 2034
Figure 94: Western Europe Market Attractiveness by Dosage Form, 2024 to 2034
Figure 95: Western Europe Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 96: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 97: Eastern Europe Market Value (US$ Mn) by Product, 2024 to 2034
Figure 98: Eastern Europe Market Value (US$ Mn) by Dosage Form, 2024 to 2034
Figure 99: Eastern Europe Market Value (US$ Mn) by Distribution Channel, 2024 to 2034
Figure 100: Eastern Europe Market Value (US$ Mn) by Country, 2024 to 2034
Figure 101: Eastern Europe Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 102: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 103: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 104: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 105: Eastern Europe Market Value (US$ Mn) Analysis by Product, 2019 to 2034
Figure 106: Eastern Europe Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 109: Eastern Europe Market Value (US$ Mn) Analysis by Dosage Form, 2019 to 2034
Figure 110: Eastern Europe Market Volume (Units) Analysis by Dosage Form, 2019 to 2034
Figure 111: Eastern Europe Market Value Share (%) and BPS Analysis by Dosage Form, 2024 to 2034
Figure 112: Eastern Europe Market Y-o-Y Growth (%) Projections by Dosage Form, 2024 to 2034
Figure 113: Eastern Europe Market Value (US$ Mn) Analysis by Distribution Channel, 2019 to 2034
Figure 114: Eastern Europe Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 115: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 116: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 117: Eastern Europe Market Attractiveness by Product, 2024 to 2034
Figure 118: Eastern Europe Market Attractiveness by Dosage Form, 2024 to 2034
Figure 119: Eastern Europe Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 120: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 121: South Asia and Pacific Market Value (US$ Mn) by Product, 2024 to 2034
Figure 122: South Asia and Pacific Market Value (US$ Mn) by Dosage Form, 2024 to 2034
Figure 123: South Asia and Pacific Market Value (US$ Mn) by Distribution Channel, 2024 to 2034
Figure 124: South Asia and Pacific Market Value (US$ Mn) by Country, 2024 to 2034
Figure 125: South Asia and Pacific Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 126: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 127: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 128: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 129: South Asia and Pacific Market Value (US$ Mn) Analysis by Product, 2019 to 2034
Figure 130: South Asia and Pacific Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 131: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 132: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 133: South Asia and Pacific Market Value (US$ Mn) Analysis by Dosage Form, 2019 to 2034
Figure 134: South Asia and Pacific Market Volume (Units) Analysis by Dosage Form, 2019 to 2034
Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Dosage Form, 2024 to 2034
Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Dosage Form, 2024 to 2034
Figure 137: South Asia and Pacific Market Value (US$ Mn) Analysis by Distribution Channel, 2019 to 2034
Figure 138: South Asia and Pacific Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 139: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 140: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 141: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034
Figure 142: South Asia and Pacific Market Attractiveness by Dosage Form, 2024 to 2034
Figure 143: South Asia and Pacific Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 144: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 145: East Asia Market Value (US$ Mn) by Product, 2024 to 2034
Figure 146: East Asia Market Value (US$ Mn) by Dosage Form, 2024 to 2034
Figure 147: East Asia Market Value (US$ Mn) by Distribution Channel, 2024 to 2034
Figure 148: East Asia Market Value (US$ Mn) by Country, 2024 to 2034
Figure 149: East Asia Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 150: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 151: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 152: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 153: East Asia Market Value (US$ Mn) Analysis by Product, 2019 to 2034
Figure 154: East Asia Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 155: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 156: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 157: East Asia Market Value (US$ Mn) Analysis by Dosage Form, 2019 to 2034
Figure 158: East Asia Market Volume (Units) Analysis by Dosage Form, 2019 to 2034
Figure 159: East Asia Market Value Share (%) and BPS Analysis by Dosage Form, 2024 to 2034
Figure 160: East Asia Market Y-o-Y Growth (%) Projections by Dosage Form, 2024 to 2034
Figure 161: East Asia Market Value (US$ Mn) Analysis by Distribution Channel, 2019 to 2034
Figure 162: East Asia Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 163: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 164: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 165: East Asia Market Attractiveness by Product, 2024 to 2034
Figure 166: East Asia Market Attractiveness by Dosage Form, 2024 to 2034
Figure 167: East Asia Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 168: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 169: Middle East and Africa Market Value (US$ Mn) by Product, 2024 to 2034
Figure 170: Middle East and Africa Market Value (US$ Mn) by Dosage Form, 2024 to 2034
Figure 171: Middle East and Africa Market Value (US$ Mn) by Distribution Channel, 2024 to 2034
Figure 172: Middle East and Africa Market Value (US$ Mn) by Country, 2024 to 2034
Figure 173: Middle East and Africa Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 174: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 175: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 176: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 177: Middle East and Africa Market Value (US$ Mn) Analysis by Product, 2019 to 2034
Figure 178: Middle East and Africa Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 179: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 180: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 181: Middle East and Africa Market Value (US$ Mn) Analysis by Dosage Form, 2019 to 2034
Figure 182: Middle East and Africa Market Volume (Units) Analysis by Dosage Form, 2019 to 2034
Figure 183: Middle East and Africa Market Value Share (%) and BPS Analysis by Dosage Form, 2024 to 2034
Figure 184: Middle East and Africa Market Y-o-Y Growth (%) Projections by Dosage Form, 2024 to 2034
Figure 185: Middle East and Africa Market Value (US$ Mn) Analysis by Distribution Channel, 2019 to 2034
Figure 186: Middle East and Africa Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 187: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 188: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 189: Middle East and Africa Market Attractiveness by Product, 2024 to 2034
Figure 190: Middle East and Africa Market Attractiveness by Dosage Form, 2024 to 2034
Figure 191: Middle East and Africa Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 192: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
- FAQs -
What was the Value of the Flu Vaccine Market in 2019?
The global flu vaccine market was worth US$ 4,166.2 million in 2019.
What is the Sales Outlook for Flu Vaccines in 2024?
The sales outlook for flu vaccines is likely to be valued at US$ 5,831.7 million in 2024.
What is the Demand Forecast for Flu Vaccines over the Coming Decade?
The demand for flu vaccines is projected to reach a market value of US$ 11,181.3 million by the end of 2034.
What is the Growth Projection for Flu Vaccines?
The adoption of flu vaccines is projected to rise at a CAGR of 6.7% through 2034.
At What Rate is the North American Market Predicted to Grow?
The North American market for flu vaccines is forecasted to expand at a CAGR of 6.8% through 2034.
Flu Vaccine Market